Navigation Links
Iomai Patch-Based Vaccine Cut Rate of Travelers' Diarrhea by 75 Percent in Phase 2 Field Study
Date:9/18/2007

ur product candidates in development: three targeting influenza and pandemic flu and one to prevent travelers' diarrhea. For more information on Iomai, please visit http://www.iomai.com.

Some matters discussed in this press release constitute "forward-looking statements" that involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements. Such forward-looking statements include statements about the patch vaccine being a prophylaxis for travelers' diarrhea, the timing for commencing Phase 3 studies, and bringing the product candidate to market; the potential size of the market for a travelers' diarrhea vaccine; the applicability of TCI technology to other pathogens; and that, if approved, Iomai's vaccine would be the first available in the U.S. Applicable risks and uncertainties include, among others, that Iomai may not be able to enroll sufficient numbers of patients in future clinical trials; that future clinical trials may not replicate results seen in the trial described in this press release; that Iomai may be unable to obtain the regulatory approvals necessary to conduct additional clinical trials or to market any product for travelers' diarrhea; that estimates of market size overstate the number of travelers who would use such a product, if it were approved; that competitors may develop products that are safer, more effective, or more convenient to use; and the risks identified under the heading "Factors That May Impact Future Results" in Management's Discussion and Analysis of Financial Condition and Results of Operations in Iomai's Quarterly Report on Form 10-Q for the three months ended June 30, 2007, and filed with the Securities and Exchange Commission. While Iomai believes that this product candidate is amenable to self-administration, in the Phase 2 study described in this press release, medical
'/>"/>

SOURCE Iomai Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. New hope for cancer victims – will vaccine cure the deadly bug
4. Vaccine for Alzheimer’s diseas
5. New vaccine helps allergy and asthma patients
6. Man against HIV – new vaccine ready for human trials
7. New vaccine helps allergy and asthma patients
8. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
9. HIV did not arise from polio vaccine
10. Double impact vaccine
11. Vaccine Reduces antibiotic-resistant infections in Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... caring, conscientious practice you have ever been a part of. We ... we can help to achieve this goal and meet your expectations." ... ... The Dermatology Center of Dallas, a Dallas based, full-service medical and ... Foshee, MD in their practice. Dr. Foshee joins James H. ...
(Date:12/15/2009)... the release of a new report titled, “Incontinence Devices Markets ... devices used to treat and manage urinary incontinence. , ... ... -- Marketstrat is pleased to announce the release of a ... specifically addresses world markets for clinical devices used to treat ...
(Date:12/14/2009)... Young Adults, Attitudes and Behavior Regarding Pregnancy, Contraception, and ... -- Nearly all unmarried young adults ages 18-29 believe ... men and 86% of women) and say that it ... now (86% of men and 88% of women), according ... Prevent Teen and Unplanned Pregnancy. Even so: ,, ...
(Date:12/14/2009)... ABBOTT PARK, Ill. and HOLLYWOOD, Fla., Dec. ... ABT ) announced today a definitive agreement ... LIMS ), a leading provider of laboratory ... in cash. ,, The acquisition strengthens ... market, providing advanced web-based applications to help ...
(Date:12/14/2009)... -- The National Organization for Rare Disorders (NORD) today ... lifetime and annual health insurance caps. In a ... distributed widely on Capitol Hill, NORD said the current ... caps to continue for most Americans, contrary to what ... reform and welcomes the promises made by President Obama ...
Breaking Medicine News(10 mins):Health News:Jeri Beth “J.B.” Foshee, MD Joins Dermatology Center of Dallas 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2
... why some nonsmokers contract the disease, study says , , TUESDAY, ... the risk of lung cancer, even in nonsmokers, researchers report. ... gene double someones risk of developing lung cancer, regardless of ... why some nonsmokers develop the disease, said study author Dr. ...
... SMTS ) announced today that it has received ... to expand the labeling for its,INVOS Cerebral/Somatic Oximeter System., ... support our ongoing efforts,in the pediatric and neonatal ICU ... and CEO. "First, the 510(k) expands,the indication for use ...
... Academy of General,Dentistry (AGD) applauds the recent introduction ... Sen. Benjamin Cardin (D-MD) and Sen. Susan,Collins (R-ME). ... a,multi-faceted approach to oral health care through the ... assess existing federal oral health,programs and recommend improvements., ...
... Md., and Deerfield, Ill., May 27, 2008 Sucampo ... Inc. today announced that AMITIZA (lubiprostone) 8 mcg capsules ... U.S. for the treatment of Irritable Bowel Syndrome with ... AMITIZA 24 mcg capsules have been available by prescription ...
... guest editorial published in the June issue of the ... National Institute of Dental and Craniofacial Research (NIDCR) in ... United States. Authored by NIDCR Director Lawrence A. Tabak ... oral health research and the traditional research community can ...
... The,Biomedical Excellence for Safer Transfusion (BEST) Collaborative ... and medical,implications of several recent papers purporting to ... Cells leads to greater risk. The organization,will highlight ... and Human,Services (HHS) meeting of the Advisory Committee ...
Other Medicine News:Health News:Common Genetic Variant Tied to Lung Cancer Risk 2Health News:Common Genetic Variant Tied to Lung Cancer Risk 3Health News:Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling 2Health News:AGD Applauds Sen. Cardin Oral Health Initiative Bill; Urges All Senators to Co-Sponsor Measure 2Health News:AMITIZA 8 mcg now available to treat irritable bowel syndrome 2Health News:AMITIZA 8 mcg now available to treat irritable bowel syndrome 3Health News:NIDCR strategies for future scientific success 2Health News:International Research Organization Responds to Recent Studies Purporting to Show That Transfusion of Older Red Blood Cells Leads to Greater Risk 2Health News:International Research Organization Responds to Recent Studies Purporting to Show That Transfusion of Older Red Blood Cells Leads to Greater Risk 3
(Date:12/14/2009)... GeoInvesting.com, we have been tracking Tianyin Pharmaceuticals (NYSE Amex: ... hang up had been with the potential dilution from ... income guidance of $11.3 million represents a 43.0% increase ... million, the increase in shares poses some uncertainty regarding ... the share price and the Treasury method of accounting ...
(Date:12/14/2009)... HELSINKI, Dec. 14 Cancer patients in ... with the introduction of RapidArc® radiotherapy technology from ... at the only private radiotherapy clinic in the ... are using this fast and precise form of ... and cancers of the abdomen and prostate. ,, ...
(Date:12/14/2009)... When staff from a leading orthopaedic ... difficult to adjust and uncomfortable cubital tunnel splints ... Inc. (PPI) to develop a superior alternative. ... for nearly five decades, responded with the revolutionary ... it announced today. Simple to fit and ...
Breaking Medicine Technology:GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3New Cubital Tunnel Splint Specially Designed for Comfort and Less Cumbersome Fit 2Commonwealth Fund Case Study Points to Continuous Innovation at Group Health Cooperative 4643 1Commonwealth Fund Case Study Points to Continuous Innovation at Group Health Cooperative 4643 2Commonwealth Fund Case Study Points to Continuous Innovation at Group Health Cooperative 4643 3MarketArt to Provide APCO With Rapid Response at World 26apos 3Bs Largest Public Safety Communications Event 49962 1MarketArt to Provide APCO With Rapid Response at World 26apos 3Bs Largest Public Safety Communications Event 49962 2MarketArt to Provide APCO With Rapid Response at World 26apos 3Bs Largest Public Safety Communications Event 49962 3Milestone Scientific Expands Global Sales Strategy to Enhance Penetration of International Dental Markets 49960 1Milestone Scientific Expands Global Sales Strategy to Enhance Penetration of International Dental Markets 49960 2Milestone Scientific Expands Global Sales Strategy to Enhance Penetration of International Dental Markets 49960 3
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... and specific second-generation peptide-based test, DIASTAT Anti-CCP* ... of autoantibodies against the cyclic citrullinated peptide ... serum or plasma. Enabling early and accurate ... an additional tool in the diagnosis and ...
... Rapid Plasma Reagin ... rapid detection and quantitative ... serum or plasma. Uses ... to detect reagin. Kits ...
Hemagglutination slide test for the qualitative detection and quantitative determination of antibodies to streptococcal extracellular antigens in serum, plasma, or whole blood....
Medicine Products: